Biblio

Export 11 results:
Author Title [ Type(Desc)] Year
Filters: Author is Herrmann, Nathan  [Clear All Filters]
Journal Article
S. A. Chau, Chung, J., Herrmann, N., Eizenman, M., and Lanctôt, K. L., “Apathy and Attentional Biases in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 837-46, 2016.
P. Chan, Saleem, M., Herrmann, N., Mielke, M. M., Haughey, N. J., Oh, P. I., Kiss, A., and Lanctôt, K. L., “Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1235-1246, 2018.
P. B. Rosenberg, Lanctôt, K. L., Herrmann, N., Mintzer, J. E., Porsteinsson, A. P., Sun, X., and Raman, R., “Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 373-81, 2016.
L. R Jaakkimainen, Bronskill, S. E., Tierney, M. C., Herrmann, N., Green, D., Young, J., Ivers, N., Butt, D., Widdifield, J., and Tu, K., “Identification of Physician-Diagnosed Alzheimer's Disease and Related Dementias in Population-Based Administrative Data: A Validation Study Using Family Physicians' Electronic Medical Records.”, J Alzheimers Dis, vol. 54, no. 1, pp. 337-49, 2016.
K. K. Bawa, Ba, J., Kiss, A., Wang, R. D., Feng, V., Swardfager, W., Andreazza, A., Gallagher, D., Marotta, G., Herrmann, N., and Lanctôt, K. L., “Lipid Peroxidation as a Marker of Apathy and Executive Dysfunction in Patients at Risk for Vascular Cognitive Impairment.”, J Alzheimers Dis, vol. 89, no. 2, pp. 733-743, 2022.
I. Suridjan, Herrmann, N., Adibfar, A., Saleem, M., Andreazza, A., Oh, P. I., and Lanctôt, K. L., “Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 3, pp. 885-896, 2017.
M. Saleem, Herrmann, N., Dinoff, A., Mielke, M. M., Oh, P. I., Shammi, P., Cao, X., Venkata, S. Lakshmi Va, Haughey, N. J., and Lanctôt, K. L., “A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise.”, J Alzheimers Dis, vol. 60, no. 3, pp. 829-841, 2017.
Z. Ismail, Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., Gauthier, S., Geda, Y. E., Herrmann, N., Kanji, J., Lanctôt, K. L., Miller, D. S., Mortby, M. E., Onyike, C. U., Rosenberg, P. B., Smith, E. E., Smith, G. S., Sultzer, D. L., and Lyketsos, C., “The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.”, J Alzheimers Dis, vol. 56, no. 3, pp. 929-938, 2017.
D. Mohammad, Ellis, C., Rau, A., Rosenberg, P. B., Mintzer, J., Ruthirakuhan, M., Herrmann, N., and Lanctôt, K. L., “Psychometric Properties of Apathy Scales in Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1065-1082, 2018.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
S. A. Chau, Herrmann, N., Sherman, C., Chung, J., Eizenman, M., Kiss, A., and Lanctôt, K. L., “Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1339-1349, 2017.